CD8A and neoplasm: The consensus Immunoscore is one of the IHC-based scoring systems to summarize the density of CD3+ and CD8+ T-cell effectors within the central tumor and its invasive margin (29) and promisingly predict recurrence-free survival (RFS) of patients with colon cancer (29).